NO810761L - Fremgangsmaate for fremstilling av terapeutisk aktive dibenzo-cyklohepten-derivater - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive dibenzo-cyklohepten-derivater

Info

Publication number
NO810761L
NO810761L NO810761A NO810761A NO810761L NO 810761 L NO810761 L NO 810761L NO 810761 A NO810761 A NO 810761A NO 810761 A NO810761 A NO 810761A NO 810761 L NO810761 L NO 810761L
Authority
NO
Norway
Prior art keywords
preparation
cyclohepten
derivatives
procedure
therapeutic active
Prior art date
Application number
NO810761A
Other languages
English (en)
Other versions
NO155620B (no
NO155620C (no
Inventor
Gerd Steiner
Hans Peter Hofman
Horst Kreiskott
Hans-Juergen Teschendorf
Dieter Lenke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO810761L publication Critical patent/NO810761L/no
Publication of NO155620B publication Critical patent/NO155620B/no
Publication of NO155620C publication Critical patent/NO155620C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Peptides Or Proteins (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO810761A 1980-03-08 1981-03-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo(a,d)-cyklohepten-derivater. NO155620C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803009034 DE3009034A1 (de) 1980-03-08 1980-03-08 10-substituierte 5-cyanmethylendibenzo (a,d) -cycloheptne

Publications (3)

Publication Number Publication Date
NO810761L true NO810761L (no) 1981-09-09
NO155620B NO155620B (no) 1987-01-19
NO155620C NO155620C (no) 1987-04-29

Family

ID=6096682

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810761A NO155620C (no) 1980-03-08 1981-03-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo(a,d)-cyklohepten-derivater.

Country Status (12)

Country Link
US (2) US4447610A (no)
EP (1) EP0035711B1 (no)
JP (1) JPS56139446A (no)
AT (1) ATE7391T1 (no)
AU (1) AU536527B2 (no)
CA (1) CA1163265A (no)
DE (2) DE3009034A1 (no)
DK (1) DK161456C (no)
FI (1) FI75155C (no)
IE (1) IE51017B1 (no)
NO (1) NO155620C (no)
ZA (1) ZA811503B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4041463A1 (de) * 1990-12-22 1992-06-25 Basf Ag 5-cyanmethylen-10-(piperazin-1-yl)-dibenzo(a,d)cycloheptene zur bekaempfung der migraene
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1568089A1 (de) * 1951-01-28 1970-01-02 Boehringer Mannheim Gmbh Verfahren zur Herstellung tricyclischer AEthylamin-Derivate
NL279409A (no) * 1961-06-08
FR111F (no) * 1964-03-27
BE664608A (no) * 1964-05-29
US3846431A (en) * 1965-01-08 1974-11-05 Spiegelberg H Heterocyclically dibenzo(a,d)cyclohepta(1,4)dien-5-one derivatives
NL152845B (nl) * 1966-03-11 1977-04-15 Boehringer Mannheim Gmbh Werkwijze voor het bereiden van een geneesmiddel met een psychotrope en bloedsomloopstimulerende werking, alsmede het aldus verkregen gevormde geneesmiddel, en werkwijze voor het bereiden van een geneeskrachtig omega,omega-difenylalkylaminederivaat.
US3459806A (en) * 1968-02-07 1969-08-05 Sandoz Ag Benzobenzazulenes
CA1000701A (en) * 1972-07-19 1976-11-30 Leslie G. Humber Process for preparing hexahydrobenzo (6,7) cyclohepta(1,2,3-de)isoquinolines
US4399141A (en) * 1977-09-19 1983-08-16 Merck & Co., Inc. 5-Alkyl or hydroxyalkyl substituted-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imines and anticonvulsant use thereof
DE2918778A1 (de) * 1979-05-10 1980-11-20 Basf Ag 6-substituierte 11-alkylen-morphantridine

Also Published As

Publication number Publication date
JPS6411014B2 (no) 1989-02-23
IE51017B1 (en) 1986-09-03
AU6813981A (en) 1981-09-17
FI75155C (fi) 1988-05-09
FI75155B (fi) 1988-01-29
DE3009034A1 (de) 1981-09-24
IE810493L (en) 1981-09-08
EP0035711A3 (en) 1982-01-20
NO155620B (no) 1987-01-19
ZA811503B (en) 1982-04-28
AU536527B2 (en) 1984-05-10
US4548933A (en) 1985-10-22
DK101781A (da) 1981-09-09
CA1163265A (en) 1984-03-06
FI810643L (fi) 1981-09-09
JPS56139446A (en) 1981-10-30
DE3163457D1 (en) 1984-06-14
NO155620C (no) 1987-04-29
DK161456C (da) 1991-12-16
DK161456B (da) 1991-07-08
ATE7391T1 (de) 1984-05-15
EP0035711B1 (de) 1984-05-09
EP0035711A2 (de) 1981-09-16
US4447610A (en) 1984-05-08

Similar Documents

Publication Publication Date Title
GR3029308T3 (en) Medical device for the administration of active ingredients or drugs at very low doses, particularly homeopathic drugs.
AU623245B2 (en) Pharmaceutical compositions
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
GB9212450D0 (en) New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
GEP20002229B (en) Synthetic Membrane Vesicles, Method for Obtaining and Application of the Same
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
NO810761L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dibenzo-cyklohepten-derivater
NO156900B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater.
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
SE8501312D0 (sv) Etoposide oral dosage form
JPS56139468A (en) 10-substituted-5-cyanmethylene-10,11-dihydro- dibenzo(a,d)cycloheptene, manufacture and medicine containing same
NO952426L (no) Nytt legemiddel som inneholder 3,7-diazabisyklo[3,3,1Ånonan forbindelser
EP0311467A3 (en) Use of pyrroloû3,2,1-hi¨indole derivatives in the manufacture of a medicament for the treatment of diabetes
TH19526A (th) วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน
ATE82501T1 (de) Pharmazeutische mittel zur weiblichen sterilisation auf intrauterinem weg und ihre therapeutische anwendung.
DE3678729D1 (de) Neue arzneimittelzubereitung mit geregelter verabreichung des aktiven mittels, und deren herstellungsverfahren.
IT1166217B (it) Composizione farmaceutica per la terapia delle sterilita' maschile